Ensign Peak Advisors’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-252,782
| Closed | -$44.1K | – | 1794 |
|
|
2023
Q1 | $44.1K | Hold |
252,782
| – | – | ﹤0.01% | 1765 |
|
|
2022
Q4 | $101K | Sell |
252,782
-267,539
| -51% | -$106K | ﹤0.01% | 1766 |
|
|
2022
Q3 | $407K | Sell |
520,321
-88,784
| -15% | -$69.4K | ﹤0.01% | 1564 |
|
|
2022
Q2 | $1.75M | Sell |
609,105
-59,383
| -9% | -$171K | ﹤0.01% | 855 |
|
|
2022
Q1 | $4.19M | Buy |
668,488
+159,051
| +31% | +$997K | 0.01% | 641 |
|
|
2021
Q4 | $5.68M | Buy |
509,437
+35,430
| +7% | +$395K | 0.01% | 632 |
|
|
2021
Q3 | $7.74M | Sell |
474,007
-176,505
| -27% | -$2.88M | 0.02% | 498 |
|
|
2021
Q2 | $12.1M | Hold |
650,512
| – | – | 0.02% | 391 |
|
|
2021
Q1 | $9.81M | Sell |
650,512
-169,315
| -21% | -$2.55M | 0.02% | 423 |
|
|
2020
Q4 | $26.5M | Buy |
+819,827
| New | +$26.5M | 0.06% | 267 |
|